111 (NASDAQ:YI) Director Jian David Sun Sells 115,440 Shares

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 115,440 shares of 111 stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $0.22, for a total value of $25,396.80. Following the completion of the sale, the director directly owned 583,111 shares in the company, valued at approximately $128,284.42. This represents a 16.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Thursday, June 11th, Jian David Sun sold 111,100 shares of 111 stock. The shares were sold at an average price of $0.23, for a total value of $25,553.00.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total value of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total value of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $7,905.60.

111 Stock Performance

NASDAQ:YI opened at $4.28 on Friday. The stock’s 50-day simple moving average is $5.95 and its 200 day simple moving average is $5.64. The company has a market cap of $37.62 million, a P/E ratio of -3.06 and a beta of 0.60. 111, Inc. Sponsored ADR has a 52-week low of $2.48 and a 52-week high of $11.17.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, 111 currently has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.